Jackie Walker - Pacific Edge CEO - Pacific Edge Diagnostics USA Ltd (PEDUSA)

PEB -- New Zealand Stock  

NZD 0.28  0.005  1.79%

  CEO
Ms. Jackie Walker is Chief Executive Officer Pacific Edge Diagnostics USA Ltd of Pacific Edge Ltd. She has over 25 years of extensive leadership experience in commercializing medical technologies in the US and a strong general management background. Prior to joining Pacific Edge Diagnostics USA, Jackie held senior executive positions at OSspray Ltd, Ondine Biomedica, Dentsply International, a NASDAQ100 company, and Ohmeda Medical.
  CEO Since 2012      
64 3 479 5800  http://www.pacificedgedx.com
Walker graduated from Duke University with a BS degree in Engineering and received a MBA in Marketing and Finance from the University of North Carolina, Chapel Hill where she was a Morehead Fellow.

Management Efficiency

The company has return on total asset (ROA) of (81.49) % which means that it has lost $81.49 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (158.29) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 138K in total debt with debt to equity ratio (D/E) of 1.2 which is about average as compared to similar companies. Pacific Edge Limited has Current Ratio of 4.33 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 6 records

CEO Since

MAgribus BBusArvida Group Limited
N/A
Scott CoulterComvita Limited
2015
Patrick DaviesEBOS Group Limited
N/A
Michael DaniellFisher Paykel Healthcare Corpor
2016
Bill McDonaldArvida Group Limited
2014
Brett HewlettComvita Limited
2017

Entity Summary

Pacific Edge Limited, a cancer diagnostic company, develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand and internationally. Pacific Edge Limited was founded in 2001 and is headquartered in Dunedin, New Zealand. Pacific Edge operates under Diagnostics Research classification in New Zealand and is traded on New Zealand Stock Exchange.Pacific Edge Limited (PEB) is traded on New Zealand Stock Exchange in New Zealand and employs 2 people.

Pacific Edge Limited Leadership Team

Chris Gallaher, Independent Director
Parry Guilford, Chief Scientific Officer and Member of Scientific Advisory Board
James Suttie, COO
Kate Rankin, CFO
N Kasabov, Head of Knowledge Engineering Discovery Research Institute (KEDRI)
Jimmy Suttie, COO
Christopher Swann, Chairman of the Board
David Darling, CEO and Executive Director
David Band, Independent Director
David Levison, Director
Charles Sitch, Independent Director
Brent Pownall, Commercial Director of Pacific Edge Diagnostics - New Zealand
Jackie Walker, CEO - Pacific Edge Diagnostics USA Ltd (PEDUSA)
Anatole Masfen, Director
Nikola Kasabov, Head of Knowledge Engineering Discovery Research Institute (KEDRI)
Bryan Williams, Independent Director

Stock Performance Indicators

Current Sentiment - PEB

Pacific Edge Limited Investor Sentiment

Most of Macroaxis users are at this time bullish on Pacific Edge Limited. What is your perspective on investing in Pacific Edge Limited? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip
Currently Active Assets on Macroaxis
MSFT   
Purchased over 20 shares of
a day ago
Traded for 117.63
S   
Purchased over 400 shares of
a day ago
Traded for 6.39
C   
Purchased over 40 shares of
a day ago
Traded for 65.83
VMW   
Purchased few shares of
a day ago
Traded for 183.64
V   
Purchased a lot of shares of
a day ago
Traded for 154.4
Additionally take a look at Your Equity Center. Please also try World Markets Correlation module to find global opportunities by holding instruments from different markets.
Search macroaxis.com